What does AI really mean for big pharma?

Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be. AI is poised to become “the primary drug discovery tool by 2027,” according to AstraZeneca’s Global Head of Enterprise Architecture. But new artificial intelligence technologies remain ostensibly unproven in the field of pharma research and despite the hype and excitement it could yet take many years before patients reap the benefits.

If you would like to receive a copy via email instead, please email enquiryiqpc@iqpc.com

Please note: That all fields marked with an asterisk (*) are required.

Please Enter Your First Name
Please Enter Your Last Name
Please Enter Your Job Title
Please Enter Your Company Name
Please Enter Your Email Address
Please Enter Your Telephone
Please Select Your Country